Sujal M. Patel - 05 Aug 2022 Form 4 Insider Report for Nautilus Biotechnology, Inc. (NAUT)

Role
CEO, President, and Secretary, Director, 10%+ Owner
Signature
/s/ Matthew B. Murphy, as Attorney-in-Fact
Issuer symbol
NAUT
Transactions as of
05 Aug 2022
Net transactions value
+$146,090
Form type
4
Filing time
08 Aug 2022, 19:48:58 UTC
Previous filing
10 May 2022
Next filing
01 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAUT Common Stock Purchase $121,646 +41,654 +0.42% $2.92 10,006,142 05 Aug 2022 Direct F1
transaction NAUT Common Stock Purchase $24,444 +8,346 +0.08% $2.93 10,014,488 08 Aug 2022 Direct F2
holding NAUT Common Stock 5,280,476 05 Aug 2022 By PFV I, LLC F3
holding NAUT Common Stock 1,814,035 05 Aug 2022 By Sujal Patel 2020 Children's Trust, u/a/d December 3, 2020 F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average share price of an aggregate total of 41,654 shares purchased in the price range of $2.76 to $3.00 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F2 Represents the weighted average share price of an aggregate total of 8,346 shares purchased in the price range of $2.90 to $3.00 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F3 Shares held by PFV I, LLC. The reporting person is the manager of PFV I, LLC.
F4 Shares held by Sujal Patel 2020 Children's Trust, u/a/d December 3, 2020 (the "Patel Trust"). The reporting person and the reporting person's spouse are the trustees of the Patel Trust.